Literature DB >> 10471369

CD39 as a caveolar-associated ectonucleotidase.

A Kittel1, E Kaczmarek, J Sevigny, K Lengyel, E Csizmadia, S C Robson.   

Abstract

CD39 is a human lymphoid cell activation antigen, (also referred to E-ATPDase or apyrase) that hydrolyzes extracellular ATP and ADP. Although it has been widely studied, its physiological role, however, still remains unclear. This ectonucleotidase generally is said to be evenly distributed in the membrane of the cells. However, we observed that in cell types which possess caveolae, specialised membrane invaginations involved in signalling, CD39 is preferentially targeted to these membrane microdomains. Since all molecules involved in signalling (eNOS, G-proteins, receptors) which are targeted to the caveolae undergo posttranslational modifications (e.g., palmitoylation) we hypothesize the same to be the case for CD39. Furthermore, its presence in the caveolae supports its participation in signalling events. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471369     DOI: 10.1006/bbrc.1999.1254

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury.

Authors:  Ming Cai; Zachary M Huttinger; Heng He; Weizhi Zhang; Feng Li; Lauren A Goodman; Debra G Wheeler; Lawrence J Druhan; Jay L Zweier; Karen M Dwyer; Guanglong He; Anthony J F d'Apice; Simon C Robson; Peter J Cowan; Richard J Gumina
Journal:  J Mol Cell Cardiol       Date:  2011-09-12       Impact factor: 5.000

2.  Expression of ecto-nucleoside triphosphate diphosphohydrolase1-3 (NTPDase1-3) by cortical astrocytes after exposure to pro-inflammatory factors in vitro.

Authors:  Dusica Brisevac; Aleksandar Bajic; Ivana Bjelobaba; Milena Milosevic; Mirjana Stojiljkovic; Cordian Beyer; Tim Clarner; Markus Kipp; Nadezda Nedeljkovic
Journal:  J Mol Neurosci       Date:  2013-08-29       Impact factor: 3.444

3.  The GDA1_CD39 superfamily: NTPDases with diverse functions.

Authors:  Aileen F Knowles
Journal:  Purinergic Signal       Date:  2011-01-21       Impact factor: 3.765

4.  Adenosine and blood platelets.

Authors:  Hillary A Johnston-Cox; Katya Ravid
Journal:  Purinergic Signal       Date:  2011-02-08       Impact factor: 3.765

Review 5.  Cellular function and molecular structure of ecto-nucleotidases.

Authors:  Herbert Zimmermann; Matthias Zebisch; Norbert Sträter
Journal:  Purinergic Signal       Date:  2012-05-04       Impact factor: 3.765

6.  Transient changes in the localization and activity of ecto-nucleotidases in rat hippocampus following lipopolysaccharide treatment.

Authors:  Agnes Kittel; Beata Sperlágh; Julie Pelletier; Jean Sévigny; Terence L Kirley
Journal:  Int J Dev Neurosci       Date:  2007-05-17       Impact factor: 2.457

7.  Histamine-induced myosin light chain phosphorylation breaks down the barrier integrity of cultured corneal epithelial cells.

Authors:  Ying Guo; Charanya Ramachandran; Minati Satpathy; Sangly P Srinivas
Journal:  Pharm Res       Date:  2007-05-04       Impact factor: 4.200

8.  Attenuated allergic airway inflammation in Cd39 null mice.

Authors:  M Idzko; C K Ayata; T Müller; T Dürk; M Grimm; K Baudiß; R P Vieira; S Cicko; C Boehlke; A Zech; S Sorichter; J Pelletier; J Sévigny; S C Robson
Journal:  Allergy       Date:  2013-03-01       Impact factor: 13.146

Review 9.  Mechanisms of induction of adenosine receptor genes and its functional significance.

Authors:  Cynthia St Hilaire; Shannon H Carroll; Hongjie Chen; Katya Ravid
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

10.  The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active.

Authors:  Corinne Barat; Geneviève Martin; Adrien R Beaudoin; Jean Sévigny; Michel J Tremblay
Journal:  J Mol Biol       Date:  2007-05-10       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.